Related Experiment Video

Updated: Mar 19, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Restoration of tumor suppressor functions by small-molecule inhibitors

Slovénie Pyndiah1, Daitoku Sakamuro2

  • 1Université Paris Diderot ; INSERM UMRS1162 ; Paris, France.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Chemical activation of tumor suppressors, like bridging integrator-1 (BIN1), offers a promising cancer therapy strategy. This approach aims to restore tumor suppressor pathways, with potential benefits and drawbacks discussed.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Tumor suppressor proteins are crucial in preventing cancer development.
  • Restoring the function of these proteins is a key therapeutic strategy in oncology.
  • Bridging integrator-1 (BIN1) is a key tumor suppressor protein with implications in cancer therapy.

Purpose of the Study:

  • To explore the potential of chemical activation of tumor suppressors for cancer treatment.
  • To evaluate the advantages and disadvantages of targeting tumor suppressor pathways, specifically BIN1.
  • To provide insights into the mechanism of action of BIN1 and its therapeutic potential.

Main Methods:

  • Review of recent findings on bridging integrator-1 (BIN1).
  • Analysis of existing data on tumor suppressor protein mechanisms.
  • Exploration of chemical activation strategies for tumor suppressors.

Main Results:

  • Accumulating data have advanced the understanding of tumor suppressor protein mechanisms.
  • Chemical activation of tumor suppressors presents a promising avenue for cancer therapy.
  • BIN1 serves as a relevant model for exploring these therapeutic strategies.

Conclusions:

  • Restoring tumor suppressor pathways is a viable strategy for cancer treatment.
  • Chemical activation of BIN1 and other tumor suppressors holds therapeutic promise.
  • Careful consideration of advantages and disadvantages is essential for developing these therapies.
Keywords:
BIN1RB1p53small-molecule inhibitortumor suppressor

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K